House Seeking CBO Scores On Public Option Alternatives Using Medicare, Negotiated Rates
This article was originally published in The Pink Sheet Daily
Speaker Pelosi says new estimates will help determine which type of public option will be part of health reform legislation sent to the House floor.
You may also be interested in...
Senate Finance Defeats Public Plan Tied To Medicare Rates; Debate Will Move To House-Senate Conference
Public option amendments voted down by the Senate Finance Committee, but debate over the public plan and linking it to Medicare rates is kicked further down the road to conference process.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.